lithocholic acid has been researched along with Cancer of Prostate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barocelli, E; Giorgio, C; Hassan-Mohamed, I; Incerti, M; Lodola, A; Mor, M; Noberini, R; Pala, D; Pasquale, EB; Piersanti, S; Rivara, S; Russo, S; Tognolini, M; Vicini, P | 1 |
| Arnold, LA; Bikle, DD; Bogart, JW; Cook, JM; Preston, JV; Sanchez, LM; Silvaggi, NR; Teske, KA; Yu, OB | 1 |
| Ballabeni, V; Callegari, D; Castelli, R; Chiodelli, P; Corrado, M; Ferlenghi, F; Giorgio, C; Incerti, M; Lodola, A; Rusnati, M; Russo, S; Scalvini, L; Tognolini, M; Vacondio, F | 1 |
| Alexander, A; Chella, N; Gangasani, JK; Gawali, B; Jannu, AK; Marepally, S; Naidu, VGM; Puppala, ER; Syamprasad, NP | 1 |
4 other study(ies) available for lithocholic acid and Cancer of Prostate
| Article | Year |
|---|---|
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor.
Topics: Adenocarcinoma; Amino Acids; Enzyme-Linked Immunosorbent Assay; Humans; Lithocholic Acid; Male; Models, Molecular; Phosphorylation; Prostatic Neoplasms; Receptor, EphA2 | 2013 |
Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
Topics: Calcitriol; Cell Line, Tumor; Cholesterol; Glucuronates; Humans; Lithocholic Acid; Male; Prostatic Neoplasms; Receptors, Calcitriol; Transcription, Genetic; Vitamin D; Vitamin D3 24-Hydroxylase | 2016 |
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Chick Embryo; Chickens; Chorioallantoic Membrane; Humans; Lithocholic Acid; Male; Models, Molecular; Neovascularization, Physiologic; Phosphorylation; Polycyclic Compounds; Prostatic Neoplasms; Protein Kinase Inhibitors; Receptor, EphA2; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor.
Topics: Cell Line, Tumor; Humans; Lithocholic Acid; Male; Micelles; Niclosamide; Prostatic Neoplasms; Receptor, EphA2; Tryptophan; Wnt Signaling Pathway | 2021 |